MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2025 International Congress

    Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae

    N. Choudhury, S. Shugar, B. Carr (Gainesville, USA)

    Objective: To investigate the impact of dioxins on movement disorder development and the mechanisms increasing vulnerability to future motor dysfunction. Background: Dioxins are persistent organic…
  • 2025 International Congress

    Single- and Multi-Unit Activity in STN Provides Enhanced Insight into Speech-Related Neural Dynamics in Parkinson’s Patients

    Z. Jourahmad, A. Rohl, J. Greenlee (Iowa City, USA)

    Objective: We aimed to elucidate neural representations in local field potentials (LFP) and single- and multi-unit activity of subthalamic nucleus (STN) neurons during speech tasks,…
  • 2025 International Congress

    Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

    R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)

    Objective: To describe methodological considerations related to stakeholder engagement in community-based participatory research (CBPR) to create a dance and music-based program (DMBP) for people with…
  • 2025 International Congress

    Daily Activity Analysis of Parkinson’s Disease Using Machine Learning with 3D Poses

    KD. Kim, S. Lyu, T. Dunn (Durham, USA)

    Objective: This study aims to find a digital behavioral marker Parkinson’s disease (PD) in activities of daily living via machine learning (ML) analysis of 3D…
  • 2025 International Congress

    Dose Optimization of Foslevodopa/Foscarbidopa: Post Hoc Analysis of Study Completers

    J. Aldred, M. Bouchard, D. Kern, P. Mir, L. Bergmann, R. Gupta, M. O'Meara, J. Samuelsson, B. Bergmans (Spokane, USA)

    Objective: To describe dose optimization, efficacy, and safety of foslevodopa/foscarbidopa (LDp/CDp) in patients with advanced Parkinson’s disease (PwaPD) who completed a 52-week open-label study. Background:…
  • 2025 International Congress

    Characterization of neuronal exosomes purified from plasma of Parkinson’s Disease Chilean patients

    V. Urbina, C. Aguilera, E. Larraechea, D. Sepulveda, R. Vidal (Santiago, Chile)

    Objective: The diagnosis of PD is usually late and has only palliative treatments that seek to slow the progression of motor symptoms. These characteristics make…
  • 2025 International Congress

    Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach

    T. Thies, F. Dörr, A. König, N. Linz, M. Barbe, J. Orozco-Arroyave, J. Rusz, J. Tröger (Saarbrücken, Germany)

    Objective: To investigate the validity and robustness of an automatically generated intelligibility score in Parkinson’s disease (PD) across multiple languages. Background: 90% of people with…
  • 2025 International Congress

    Foscarbidopa/Foslevodopa Therapy Improves Continuous Duration of Good ON Time and Correlated With Quality of Life in People With Parkinson’s Disease

    M. Bouchard, R. Hauser, P. Odin, D. Kern, S. Isaacson, L. Bergmann, L. Harmer, J. Homola, R. Gupta, C. Yan, C. Carroll (North Chicago, USA)

    Objective: To assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on longest consecutive duration of Good and Best ON time and association of…
  • 2025 International Congress

    Global Cognition Influences Non-Tremor Motor Decline in Parkinson’s Disease

    M. Gibbs, A. D'Souza, C. Sotirakis, T. Crawford, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To explore the longitudinal association between global cognition and i) global motor, ii) tremor, and iii) non-tremor motor severity and progression. Background: Impaired voluntary movement…
  • 2025 International Congress

    Effect of Sensory Feedback Vibration Stimulation Using an In-Sole Foot Pressure Monitor on Gait

    K. Kakegawa, T. Matsuda, J. Ogawa, Y. Yamaguchi, K. Fujinawa (Bunkyo-ku, Tokyo, Japan)

    Objective: To investigate the effects of a sensory feedback vibration stimulation device that integrates an insole foot pressure sensor on gait. Background: Foot pressure during…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley